Discover and read the best of Twitter Threads about #asco18
Most recents (1)
Here are my Top 5 #ASCO19 @ASCO myeloma abstracts. #ASCO19VR
I’ve listed them with links to the full abstract. @mtmdphd @myelomaMD @MyelomaTeacher @MayoMyeloma @NorthTxMSG @Mohty_EBMT @BldCancerDoc @DrAnasYounes @DrMiguelPerales @JohnPLeonardMD
See thread for countdown! 👇
I’ve listed them with links to the full abstract. @mtmdphd @myelomaMD @MyelomaTeacher @MayoMyeloma @NorthTxMSG @Mohty_EBMT @BldCancerDoc @DrAnasYounes @DrMiguelPerales @JohnPLeonardMD
See thread for countdown! 👇
#5 Isatuximab-Pom-Dex vs Pom-Dex in relapsed refractory myeloma. First phase III with this drug. May lead to FDA approval and provide alternative to Dara (?compete on cost) @DanaFarber @sanofi @mtmdphd @grpetersen1 #ASCO19 #ASCO19VR
abstracts.asco.org/239/AbstView_2…
abstracts.asco.org/239/AbstView_2…
#4 IMWG Risk stratification for Smoldering Myeloma. ~2000 patient study defines intermediate & high risk smoldering myeloma with simple parameters. Of importance: identifies candidates for early therapy. @mvmateos @myelomaMD @IMFmyeloma #ASCO19 #ASCO19VR
abstracts.asco.org/239/AbstView_2…
abstracts.asco.org/239/AbstView_2…
